Histone Deacetylase Inhibitors Globally Enhance H3/H4 Tail Acetylation Without Affecting H3 Lysine 56 Acetylation

Histone deacetylase inhibitors (HDACi) represent a promising avenue for cancer therapy. We applied mass spectrometry (MS) to determine the impact of clinically relevant HDACi on global levels of histone acetylation. Intact histone profiling revealed that the HDACi SAHA and MS-275 globally increased...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Drogaris, Paul, Villeneuve, Valérie, Pomiès, Christelle, Lee, Eun-Hye, Bourdeau, Véronique, Bonneil, Éric, Ferbeyre, Gerardo, Verreault, Alain, Thibault, Pierre
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256565/
https://ncbi.nlm.nih.gov/pubmed/22355734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep00220
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares